Broadwood Partners, L.P., 10% Owner at Oncocyte Corp (OCX), bought 2,420,000 shares at $2.92 ($7.1M) on 2024-04-11, disclosed to the SEC on 2024-04-15.
Open-market purchase of $7.1M OCX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| STAA | BUY | 2026-03-13 | $12.3M | — | Filing → |
| STAA | BUY | 2026-01-08 | $8.8M | — | Filing → |
| STAA | BUY | 2025-04-07 | $27.2M | — | Filing → |